Educational background: Tirzepatide as a molecule was developed by Eli Lilly and Company and is sold under the brand names Mounjaro (for type 2 diabetes) and Zepbound (for chronic weight management)
Fridays is a specialized GLP-1 subscription service focused on weight loss with a fixed monthly model
Two things separate this review from every other result in your search: first, it tells you exactly what the brand can't or won't tell you upfront - including the fact that the full ingredient list isn't published on the official site
Microdosing Wegovy and other GLP-1 medications is becoming more popular as the cost of weight loss injections rises
These types of studies establish confidence in the outcomes, as neither the scientists nor the participants are aware of who receives actual medication versus a placebo during the trial
However, a needed framing of this question is not whether GLP-1 medications induce SMM loss at all, but rather does greater SMM loss occur as compared to the normal degree of SMM loss that occurs with other weight loss interventions